Internal Medicine, Pulmonary Disease · Prospect, KY
NPI
1801878806
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
10214 Worthington Ln
Prospect, KY, 40059
Phone (502) 216-0191
Groups this clinician bills Medicare through
Medicare paid, 2024
$591K
7,256 services
Medicare patients, 2024
1,785
Average age 73
Drug cost, 2024
$6.2M
18,011 prescriptions
Company payments, 2025
$30K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Azmi Draw was code 99233 (hospital e&m - subsequent), 1,824 times for 352 patients. In total Azmi Draw billed 7,256 services in 50 codes, and Medicare paid $591K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,824 | 352 | $87.55 | $160K |
| 99215 Office E&M - Established | Office | 1,462 | 828 | $129.91 | $190K |
| 99307 SNF E&M | Facility | 771 | 151 | $29.04 | $22K |
| 99223 Hospital E&M - Initial | Facility | 409 | 362 | $127.24 | $52K |
| 99214 Office E&M - Established | Office | 265 | 229 | $92.58 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 236 | 226 | $12.23 | $2,886 |
| 99291 Critical Care E&M | Facility | 224 | 83 | $156.56 | $35K |
| 94664 E&M - Miscellaneous | Office | 161 | 140 | $12.76 | $2,054 |
| 94060 Pulmonary Function Testing | Facility | 157 | 154 | $7.53 | $1,182 |
| 94726 Pulmonary Function Testing | Facility | 157 | 154 | $8.81 | $1,383 |
| 94729 Pulmonary Function Testing | Facility | 157 | 154 | $6.51 | $1,022 |
| 99215 Office E&M - Established | Facility | 140 | 92 | $106.09 | $15K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 136 | 69 | $53.27 | $7,245 |
| 31624 Bronchoscopy | Facility | 130 | 120 | $24.09 | $3,132 |
| 99204 Office E&M - New | Office | 129 | 129 | $118.41 | $15K |
By year: 2022 $1.0M for 11,834 services; 2023 $826K for 10,149 services; 2024 $591K for 7,256 services.
Medicare prescription drug claims, 2024
In 2024, the drug Azmi Draw prescribed most often to Medicare patients was Theophylline Er (Theophylline Anhydrous), with 1,402 prescriptions and refills. In total Azmi Draw wrote 18,011 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Theophylline Er Theophylline Anhydrous | 1,402 | 2,423 | 280 | $76K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 997 | 1,204 | 189 | $762K |
| Montelukast Sodium Generic | 988 | 1,710 | 223 | $5,836 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 862 | 1,003 | 290 | $18K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 720 | 949 | 189 | $578K |
| Atorvastatin Calcium Generic | 510 | 528 | 81 | $9,295 |
| Prednisone Generic | 370 | 423 | 168 | $1,310 |
| Eliquis Apixaban | 365 | 365 | 31 | $107K |
| Breo Ellipta Fluticasone/Vilanterol | 340 | 393 | 61 | $148K |
| Furosemide Generic | 308 | 330 | 71 | $2,488 |
| Azithromycin Generic | 284 | 402 | 152 | $2,663 |
| Omeprazole Generic | 282 | 299 | 64 | $3,538 |
| Roflumilast Generic | 259 | 314 | 48 | $14K |
| Amlodipine Besylate Generic | 241 | 263 | 42 | $2,489 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 226 | 258 | 50 | $118K |
Brand drugs: 5,597 claims; generic drugs: 12,280 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Azmi Draw $30K ($30K in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $21K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 44 | $21K |
| Verona Pharma, Inc. VRNA | 26 | $6,983 |
| GlaxoSmithKline, LLC. GSK | 27 | $419 |
| Harmony Biosciences LLC HRMY | 11 | $282 |
| Insmed, Inc. INSM | 16 | $256 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $200 |
| Amgen Inc. AMGN | 10 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $122 |
| Genzyme Corporation SNY | 5 | $96.67 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $89.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.